Lacticaseibacillus Rhamnosus

Overview

Lacticaseibacillus rhamnosus (L. rhamnosus) is a probiotic bacteria that is available over the counter as a supplement and in some fermented foods. It is commonly used for diarrhea and to improve the health of the gut and immune system, but its benefits for most uses are not well defined. Common side effects include gas and an upset stomach. Serious side effects are rare and include infections in some people who are at high risk of infections. Before taking L. rhamnosus, make sure to tell your health care provider about any health conditions you have or medicines you are taking.

References
  1. American Journal of Clinical Dermatology: “Lactobacillus rhamnosus used in the perinatal period for the prevention of atopic dermatitis in infants: A systematic review and meta-analysis of randomized trials.”
  2. The Cochrane Database of Systematic Reviews: “Probiotics for treating acute infectious diarrhoea.”
  3. Journal of Pediatric Gastroenterology and Nutrition: “Lactobacilli and Bifidobacteria in human breast milk: influence of antibiotherapy and other host and clinical factors.”
  4. National Center for Complementary and Integrative Health: “5 Things To Know About Probiotics,” “Probiotics: Usefulness and Safety.”
  5. National Institutes of Health, Office of Dietary Supplements: Probiotics, Fact Sheet for Consumers,” “Probiotics, Fact Sheet for Health Professionals.”
  6. Scientific Reports: “Effect of Lacticaseibacillus rhamnosus IDCC 3201 on irritable bowel syndrome with constipation: a randomized, double-blind, and placebo-controlled trial.”
  7. The New England journal of medicine: “Lactobacillus rhamnosus GG versus placebo for acute gastroenteritis in children.”
  8. Nutrients: “Lactobacillus rhamnosus GG in the primary prevention of eczema in children: A systematic review and meta-analysis.”
  9. Preventive Nutrition and Food Science: “Role of Lacticaseibacillus rhamnosus GG in the Management of respiratory diseases: a systematic review and meta-analysis.”
  10. FDA: “FDA Raises Concerns About Probiotic Products Sold for Use in Hospitalized Preterm Infants.”
  11. World Journal of Gastroenterology: “Efficacy of Lactobacillus rhamnosus GG in treatment of acute pediatric diarrhea: A systematic review with meta-analysis.”